Hypertension Therapy Flashcards
what is the step line therapy for HTN in stable ischemic heart disease
-first line: beta blockers
may also use ACEi, ARB
-CCBs can be used if BP still uncontrolled
what is the step line therapy for HTN in heart failure
-reduced ejection fractions: follow most recent HF guidelines. avoid non DHPs
-preserved ejection fraction: diurectics, ACEi/ARB, beta blocker
what is the step line therapy for HTN in CKD
-CKD stage 1 or 2 and albuminuria: ACEi or ARB
-CKD stage 3 or higher: ACEi or ARB
what is the step line therapy for HTN in cerebrovascular disease
ACEi/ARB, thiazide diuretic, or combo
what is the step line therapy for HTN in diabetes
all first line classes are good options
if albuminuria use ACEi or ARB
what is the step line therapy in HTN for pregnancy
methyldopa, nifedipine, labetalol
contraindications: ACEi, ARB, direct renin inhibitors
what HTN therapy works best in black patients
Thiazide or CCB unless HF or CKD
thiazide diuretic drug choices
HCTZ, chlorthalidone, indapamide, metolazone
thiazide adverse effects
-hypokalemia
-hyperuricemia
-sexual dysfunction
-increase in lipids
thiazide DDIs
lithium toxicity w/ concurrent use
thiazide contraindications
sulfa allergy
anuria
aldosterone antagonists drug choices
spironolactone, eplerenone
aldosterone adverse effects
-hyperkalemia
-hyponatremia
-gynecomastia
aldosterone DDIs
ACEi/ARB/renin inhibitors/NSAIDs
increase risk of hyperkalemia
aldosterone contraindications
concomitant use of potassium sparing diuretics
Potassium sparing diuretics agents
amiloride, triamterene
diuretic clinical pearls
-don’t dose at bedtime
-thiazides are first line for most HTN
-spironolactone is first line for resistant HTN
-don’t use potassium sparing as monotherapy
-check CrCl when choosing diuretic
-monitor potassium (and other electrolytes)
ACEi mechanism
inhibits conversion for angiotensin I to angiotensin II
ARB mechanism
block effects of angiotensin II by binding to target receptors
renin inhibitors mechanism
inhibits conversion of angiotensinogen to angiotensin I
ACEi agents
“prils”
ACEi adverse effects
-angioedema
-cough
-hyperkalemia
-acute renal failure